Critical Path Institute (C-Path)
Michael Minchik has a diverse work experience spanning across various companies. Michael started their career at Lonza as a Core Tech II in 2006. Michael then joined SAIC-Frederick as a Research Technician in 2008 and later became a Supervisor/Research Associate, managing PK/PD support lab employees and sampling protocols for oncology clinical trials. Michael was recognized with the RESPECT award in 2011 for their contributions. In 2014, they transitioned to Leidos Biomedical Research, where they worked as a Supervisor/Research Associate II, overseeing operations of the PK/PD support lab and earning an individual achievement award. In 2017, they moved to the Critical Path Institute (C-Path) and held several roles, including Project Manager, Grants Administrator, Senior Project Manager, and Associate Director. Currently, they serve as the Director, Portfolio Management Office, focusing on developing workplans and budgets for the Critical Path for Parkinson's (CPP Consortium) and providing operational support for the Neuroscience Program.
Michael Minchik completed their Bachelor of Arts (B.A.) in Biology, General from the University of Delaware in the period from 2001 to 2006. Later, they pursued a Master of Business Administration (M.B.A.) from the University of Maryland - Robert H. Smith School of Business between 2010 and 2013. No specific field of study was mentioned for their MBA.
This person is not in any offices
Critical Path Institute (C-Path)
Critical Path Institute (C-Path) is an independent, nonprofit organization established in 2005 as a public and private partnership. C-Path’s mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. An international leader in forming collaborations, C-Path has established numerous global consortia that currently include more than 1,600 scientists from government and regulatory agencies, academia, patient organizations, disease foundations, and dozens of pharmaceutical and biotech companies. C-Path U.S. is headquartered in Tucson, Arizona and C-Path, Ltd. EU is headquartered in Dublin, Ireland, with additional staff in multiple other locations. For more information, visit c-path.org and c-path.eu.